secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001453687-23-000061
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Selecta Biosciences fully repays debt under loan agreement with Oxford Finance and Silicon Valley Bank
--------------------------------------------------------------------------------

- Paid all outstanding amounts under Loan and Security Agreement dated Aug 31, 2020 (as amended).
- Accrued interest and prepayment penalty included; all obligations discharged in full.
- All unfunded commitments terminated; liens and security interests automatically released.
- Warrants previously issued to Oxford and Silicon Valley Bank remain outstanding.
- No financial amounts disclosed; company no longer has debt obligations under this agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368723000061/0001453687-23-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368723000061/selb-20230911.htm
  HTML page:      https://secwatch.observer/filing/0001453687-23-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer